Theravance Biopharma, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2013 | $-4.92 | $-3.52 |
| FY2014 | $-7.46 | $-5.64 |
| FY2015 | $-5.34 | $-6.00 |
| FY2016 | $-4.26 | $-5.91 |
| FY2017 | $-5.45 | $-6.09 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2013 | $-4.92 | $-3.52 |
| FY2014 | $-7.46 | $-5.64 |
| FY2015 | $-5.34 | $-6.00 |
| FY2016 | $-4.26 | $-5.91 |
| FY2017 | $-5.45 | $-6.09 |